AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Reg. 34 (1) Annual Report.
Submission of Annual Report 2022-2326-08-2023
26-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended 30th June 202304-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Closure of Buy Back
Completion of extinguishment of 3,20,000 (Three Lakh Twenty Thousand) fully paid-up Equity shares of Rs. 1/- (Rupee One) each under Buy-Back offer of Amrutanjan Health Care Limited04-08-2023
Deloitte finds malpractices in vendor management and casual labour onboarding by Amrutanjan employees
The Deloitte audit report said an employee has received kickback from a vendor and multiple unexplained cash to a tune of 8 lakh were deposited from 2019-202203-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Investigation Report On Whistle Blower Complaint By M/S. Deloitte Touche Tohmatsu India LLP And The Special Review Report By M/S. PKF Sridhar & Santhanam LLP Along With Company'S Management Comments.
This is in relation to the investigation initiated by the Company in furtherance to the anonymous whistle blower complaint received by the Company which was intimated to Stock exchange on February 14, 2023 under Sub-clause 17(a) of SEBI (LODR). The Company, at the instance of its Audit Committee, had engaged M/s. Deloitte Touche Tohmatsu India LLP for undertaking the investigation in this regard. The investigation was aimed at assessing the veracity of the allegations raised in the whistle blower complaint. This intimation is made under Regulation 30 read with Schedule III Part A Clause A Sub- Clause 17 (b) of the SEBI (LODR) Regulations, 201502-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Book Closure
We wish to inform you that the Board of Directors of the Company at their meeting held today (Aug 2 2023) had inter-alia approved: That the Share transfer register shall be closed from Friday, September 15, 2023 to Thursday, September 21 2023 (both days inclusive)02-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Record Date For Final Dividend - Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015(SEBI LODR)
We wish to inform you that the Board of Directors of the Company at their meeting held today (Aug 2 2023) had inter-alia approved Thursday September 14, 2023 as the Record date for the purpose of determining the eligibility criteria of shareholders to receive Final Dividend for the Financial year 2022-23 and to attend/vote at the Annual General Meeting to be held on September 21, 2023.02-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Outcome Of The Board Meeting- Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)
We wish to inform that the Board of Directors of the Company at its meeting held today (August 2, 2023) had inter- alia approved the unaudited financial results for the quarter ended June 30, 2023. The same along with the Limited Review Report issued by M/s. BSR & Co. LLP, Statutory auditors of the company is enclosed02-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Outcome for Outcome Of The Board Meeting- Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)
Pursuant to the subject regulation(s), we wish to inform that the Board of Directors of the Company at its meeting held today (August 2, 2023) had inter-alia approved - The Unaudited Financial Results for the quarter ended June 30, 2023 as recommended by the Audit Committee at its meeting held today (August 2, 2023). The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed.02-08-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement
Intimation on Submission of Post-Buyback Public announcement for buyback of equity shares of the Company through tender offer02-08-2023